Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024967
Filing Date
2022-11-14
Accepted
2022-11-14 16:02:13
Documents
60
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q meip-20220930.htm   iXBRL 10-Q 1564271
2 EX-31.1 meip-ex31_1.htm EX-31.1 20422
3 EX-31.2 meip-ex31_2.htm EX-31.2 20257
4 EX-32.1 meip-ex32_1.htm EX-32.1 14963
5 GRAPHIC img103139698_0.jpg GRAPHIC 132628
  Complete submission text file 0000950170-22-024967.txt   7038938

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT meip-20220930_def.xml EX-101.DEF 242163
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20220930.xsd EX-101.SCH 47388
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20220930_pre.xml EX-101.PRE 311985
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20220930_lab.xml EX-101.LAB 419835
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT meip-20220930_cal.xml EX-101.CAL 37785
54 EXTRACTED XBRL INSTANCE DOCUMENT meip-20220930_htm.xml XML 1271552
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 221384905
SIC: 2834 Pharmaceutical Preparations